| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 3.55B | 4.24B | 3.50B | 3.29B | 2.75B |
| Gross Profit | 1.91B | 3.12B | 2.22B | 1.87B | 1.78B | 1.70B |
| EBITDA | 2.34B | 3.10B | 2.42B | 2.23B | 2.26B | 2.16B |
| Net Income | 992.00M | 1.26B | 1.14B | 671.00M | 1.50B | 1.10B |
Balance Sheet | ||||||
| Total Assets | 35.95B | 35.79B | 33.52B | 32.47B | 27.36B | 26.13B |
| Cash, Cash Equivalents and Short-Term Investments | 2.42B | 1.81B | 1.38B | 1.76B | 1.34B | 3.04B |
| Total Debt | 19.99B | 18.36B | 16.65B | 13.68B | 15.36B | 15.94B |
| Total Liabilities | 26.77B | 26.82B | 25.93B | 24.95B | 20.12B | 19.66B |
| Stockholders Equity | 9.14B | 8.93B | 7.63B | 7.47B | 7.20B | 6.47B |
Cash Flow | ||||||
| Free Cash Flow | -791.00M | -1.00B | -1.68B | 2.79B | 94.00M | 431.00M |
| Operating Cash Flow | 1.88B | 1.81B | -135.00M | 4.11B | 1.34B | 1.60B |
| Investing Cash Flow | -3.13B | -2.68B | -2.23B | -1.36B | -1.64B | -1.64B |
| Financing Cash Flow | 1.14B | 1.29B | 1.99B | -2.32B | -1.41B | 233.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | €18.60B | 10.27 | 12.14% | 4.14% | -11.36% | -20.23% | |
73 Outperform | €701.06M | 8.43 | 9.91% | 4.82% | 20.11% | ― | |
72 Outperform | €18.04B | 16.31 | 19.67% | 4.41% | 10.18% | 8.43% | |
70 Outperform | €18.28B | 13.09 | 17.62% | 5.19% | -8.04% | 30.49% | |
69 Neutral | €9.48B | 16.84 | ― | 4.11% | -3.34% | 8.88% | |
66 Neutral | €4.45B | 13.47 | 13.05% | 7.68% | 18.52% | 29.29% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |